Stroke Prevention In Patients With Atrial Fibrillation- Pharmacist




This product is currently out of stock and unavailable.

Atrial fibrillation (AF) is a complex, yet common heart arrhythmia. Individuals with AF may experience a variety of symptoms – or no symptoms at all. In fact, up to 87% of adults are initially asymptomatic. Those with symptoms will complain of palpitations, shortness of breath, fatigue, chest tightness/pain, dizziness, or fainting. Additionally, individuals with AF have a 4- to 5-fold increased risk of stroke, with a 1.5-fold (men) to 2-fold (women) increased risk of death. In addition to general risk factors, the prevalence of AF increases with age – and the US population is growing older. By the year 2030, an estimated 12.1 million people in the US will be diagnosed with AF.


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience


Kimberly M. Crosby
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • Discuss the recommendations for anticoagulation based upon a patient's risk factors for stroke, including their CHA2DS2-VASc and HAS-BLED scores.
  • Compare and contrast the clinical use and safety profiles of DOACs and warfarin in patients with AF. 
  • Describe the use of DOACs in special populations including older patients, obese patients, patients with chronic kidney disease, and patients who are undergoing surgical procedures. Discuss the use of reversal agents in the management of bleeding from DOACs.
  • Counsel a patient regarding DOAC administration, the signs of bleeding linked to anticoagulation, and the signs of a stroke.

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0798-0000-21-186-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.